Soon, California residents with personal care needs will be eligible for Medicaid long-term care no matter how much money and other assets they have. On July 1, the state will increase the program’s asset limit from $2,000 for an individual to $130,000 and from $3,000 for a couple to $195,000. The state plans to end the limit entirely as soon [...]
The Biden Administration has proposed a wide range of changes in the regulation of nursing homes. They include efforts to require minimum staffing levels; limit shared rooms; enhance inspections, penalties, and transparency; and crack down on owners with a history of poor quality. The plan also would expand a technical assistance program to help operators improve their quality of care. [...]
By now, you’ve probably heard about the desperate shortage of nurses and aides in nursing homes and long-term care facilities. This workforce crisis not only hurts their residents, it also is creating severe backups in hospitals, putting both patients and the facilities themselves at risk and increasing health care costs. As those staffing shortages course through the entire health care [...]
Over just the past few decades, the life expectancy of people with Down Syndrome (DS) has increased from less than 30 years to nearly 60. But for many, that remarkable advancement comes at a high price. As they live longer, up to ninety percent of people with DS will have Alzheimer’s Disease. It is, in fact, the leading cause of death [...]
With nursing homes and other long-term care facilities desperately short of nurses and aides, it is more important than ever for consumers to know about staffing levels, quality, and turnover. But it has been difficult to get some key information. Now, the government has taken a modest step to help. In January, the Centers for Medicare and Medicaid Services (CMS) [...]
In a key decision, the Centers for Medicare and Medicaid Services (CMS) said today that Medicare will not pay for the controversial Alzheimer’s drug Adulhelm until it sees positive results from a government-approved trial. In bureaucratic language: “Monoclonal antibodies directed against amyloid for the treatment of [Alzheimer’s Disease] provided outside of the CMS approved randomized controlled trials and trials supported [...]
An effort to repeal Washington State’s public long-term care insurance program failed to get enough signatures by the end-of-year deadline to make it on the November ballot. At the same time, Democrats, who control the state legislature, have introduced multiple bills aimed at delaying or revising the program. The state was scheduled to start collecting a mandatory 0.58 percent payroll [...]
Is it possible that Congress will do nothing to improve long-term services and supports for older adults and younger people with disabilities or assist their families? Even after 603,000 people over age 65 were killed by Covid-19 in the past two years. Yes, it is possible. The House version of President Biden’s Build Back Better plan included many provisions aimed [...]
This week, drugmaker Biogen made a stunning announcement: It is going to cut in half the price of its controversial Alzheimer’s drug Aduhelm. Instead of selling the infusion drug for $56,000 annually to a typical user it will charge $28,000-a-year. It is, to say the least, unusual, for the maker of a potential blockbuster drug to cuts its price just [...]
Facing a lawsuit and political opposition, Washington State Governor Jay Inslee has delayed until April a payroll tax aimed at funding the state’s first-in-the-nation public long-term care insurance program. Inslee said the delay will give the legislature time to address what he called “areas that need adjustment.” A state long-term care commission advising the legislature and governor will recommend a [...]